1. Home
  2. Analysis
  3. Lorazepam
  4. Osteosarcoma-metastatic

Lorazepam and Osteosarcoma metastatic - a phase IV clinical study of FDA data

Summary:

Osteosarcoma metastatic is reported as a side effect among people who take Lorazepam (lorazepam), especially for people who are male, 40-49 old, also take Crestor, and have Hypoaesthesia.

The phase IV clinical study analyzes which people have Osteosarcoma metastatic when taking Lorazepam. It is created by eHealthMe based on reports of 161,687 people who have side effects when taking Lorazepam from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Osteosarcoma metastatic?

Osteosarcoma metastatic (a cancerous (malignant) bone tumour can spreads to other parts) is found to be associated with 64 drugs and 53 conditions by eHealthMe. Check the latest studies of Osteosarcoma metastatic.

On Jul, 09, 2026

161,687 people reported to have side effects when taking Lorazepam.
Among them, 12 people (0.01%) have Osteosarcoma metastatic.

Could Lorazepam cause Osteosarcoma metastatic?

Among these 12 people:

What is the gender of people who have Osteosarcoma metastatic when taking Lorazepam? *

  • female: 25 %
  • male: 75 %

What is the age of people who have Osteosarcoma metastatic when taking Lorazepam? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 83.33 %
  • 50-59: 0.0 %
  • 60+: 16.67 %

What are other drugs people take besides Lorazepam? *

  1. Lomotil: 10 people, 83.33%
  2. Cimetidine: 10 people, 83.33%
  3. Oxycontin: 10 people, 83.33%
  4. Lotrel: 10 people, 83.33%
  5. Zometa: 10 people, 83.33%
  6. Emcyt: 10 people, 83.33%
  7. Dyazide: 10 people, 83.33%
  8. Taxol: 10 people, 83.33%
  9. Paclitaxel: 10 people, 83.33%
  10. Crestor: 10 people, 83.33%

What are other side effects people have besides Osteosarcoma metastatic? *

  1. Pain: 12 people, 100.00%
  2. Weakness: 10 people, 83.33%
  3. Fatigue (feeling of tiredness): 10 people, 83.33%
  4. Nausea And Vomiting: 10 people, 83.33%
  5. Nutritional Condition Abnormal: 10 people, 83.33%
  6. Injury: 10 people, 83.33%
  7. Infection: 10 people, 83.33%
  8. Impaired Healing: 10 people, 83.33%
  9. Pain In Jaw: 10 people, 83.33%
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 10 people, 83.33%

What are the existing conditions these people have? *

  1. Weakness: 10 people, 83.33%
  2. Prostate Cancer: 10 people, 83.33%
  3. Hypoaesthesia (reduced sense of touch or sensation): 10 people, 83.33%
  4. Pain: 5 people, 41.67%
  5. Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
  6. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and have Osteosarcoma metastatic?

- Check whether Osteosarcoma metastatic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lorazepam:

Osteosarcoma metastatic treatments and more:

How severe was Osteosarcoma metastatic and when was it recovered:

Expand to all the drugs that have ingredients of lorazepam:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteosarcoma metastatic:

Browse all the conditions that are associated with Osteosarcoma metastatic:

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam (the active ingredients of Lorazepam) and Lorazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.